Pfizer MISSES Expectations For COVID Vaccine Sales As Biden Approval Rating & Inflation Set Records

Shares of vaccine makers slumped Tuesday, losing about $15 billion in market value, after Pfizer Inc. issued revenue guidance for its jab and pill that fell short of analyst expectations.

https://finance.yahoo.com/news/vaccine-stocks-drop-pfizer-covid-212533231.html

U.S. inflation accelerated to a 7.5% annual rate in January, reaching a four-decade high as strong consumer demand and pandemic-related supply constraints kept pushing up prices.

https://www.wsj.com/articles/us-inflation-consumer-price-index-january-2022-11644452274?mod=hp_lead_pos1&mod=hp_lead_pos1&mod=hp_lead_pos1

Legal Disclosure: I’m not a financial advisor. The information contained in this video is for entertainment purposes only. Before investing, please consult a licensed professional. Any stock purchases I show on video should not be considered “investment recommendations”. I shall not be held liable for any losses you may incur for investing and trading in the stock market in an attempt to mirror what I do. Investments may decline in value and/or disappear entirely. Please be careful!